Marex Group plc Announces Pricing of the Public Offering
25 October 2024 - 12:00AM
Marex Group plc (“Marex”) (Nasdaq: MRX), the diversified global
financial services platform, today announces the pricing of the
public offering (the “Offering”) of 8,472,333 ordinary shares by
certain selling shareholders (the “Selling Shareholders”) at $24.00
per share. In connection with the Offering, the Selling
Shareholders have granted the underwriters a 30-day option to
purchase up to an additional 1,270,849 ordinary shares.
Marex is not selling any ordinary shares in the
Offering and will not receive any proceeds from any sale of shares
by the Selling Shareholders. The Offering is expected to close on
October 25, 2024, subject to customary closing conditions.
Barclays, Goldman Sachs & Co. LLC, Jefferies
and Keefe, Bruyette & Woods, a Stifel Company, are acting as
joint lead book-running managers and as representatives of the
underwriters for the proposed Offering. Citigroup, UBS Investment
Bank, Piper Sandler & Co. and Berenberg are acting as
bookrunners for the Offering. Drexel Hamilton and Loop Capital
Markets are acting as co-managers for the Offering.
The proposed Offering is being made only by
means of a prospectus. Copies of the prospectus relating to the
proposed Offering may be obtained from:
- Barclays Capital Inc., c/o
Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood,
NY 11717, by telephone at 1-888-603-5847, or by email at
barclaysprospectus@broadridge.com;
- Goldman Sachs & Co. LLC,
Attention: Prospectus Department, 200 West Street, New York, New
York 10282, via telephone: 1-866-471-2526, or via email:
prospectus-ny@ny.email.gs.com;
- Jefferies LLC, Attention: Equity
Syndicate Prospectus Department, 520 Madison Avenue, New York, NY
10022, by phone at (877) 821-7388, or by email at
Prospectus_Department@Jefferies.com; or
- Keefe, Bruyette & Woods Inc.,
787 Seventh Avenue, Fourth Floor, New York, NY 10019, attention:
Equity Capital Markets, or by calling toll free at (800) 966-1559
or emailing USCapitalMarkets@kbw.com.
A registration statement on Form F-1 relating to
the Offering has been filed with, and was declared effective by,
the U.S. Securities and Exchange Commission (the “SEC”).This press
release does not constitute an offer to sell or the solicitation of
an offer to buy any securities, and shall not constitute an offer,
solicitation or sale in any jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of that jurisdiction.
Forward-Looking Statements
This release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
All statements contained in this release that do not relate to
matters of historical fact should be considered forward-looking
statements, including the expected closing date of the Offering. In
some cases, these forward-looking statements can be identified by
words or phrases such as “may,” “will,” “expect,” “anticipate,”
“aim,” “estimate,” “intend,” “plan,” “believe,” “potential,”
“continue,” “is/are likely to” or other similar expressions. These
forward-looking statements are subject to risks, uncertainties and
assumptions, some of which are beyond our control. In addition,
these forward-looking statements reflect our current views with
respect to future events and are not a guarantee of future
performance. Actual outcomes may differ materially from the
information contained in the forward-looking statements as a result
of a number of factors, including, without limitation: subdued
commodity market activity or pricing levels; the effects of
geopolitical events, terrorism and wars, such as the effect of
Russia’s military action in Ukraine, on market volatility, global
macroeconomic conditions and commodity prices; changes in interest
rate levels; the risk of our clients and their related financial
institutions defaulting on their obligations to us; regulatory,
reputational and financial risks as a result of our international
operations; software or systems failure, loss or disruption of data
or data security failures; an inability to adequately hedge our
positions and limitations on our ability to modify contracts and
the contractual protections that may be available to us in OTC
derivatives transactions; market volatility, reputational risk and
regulatory uncertainty related to commodity markets, equities,
fixed income, foreign exchange and cryptocurrency; the impact of
climate change and the transition to a lower carbon economy on
supply chains and the size of the market for certain of our energy
products; the impact of changes in judgments, estimates and
assumptions made by management in the application of our accounting
policies on our reported financial condition and results of
operations; lack of sufficient financial liquidity; if we fail to
comply with applicable law and regulation, we may be subject to
enforcement or other action, forced to cease providing certain
services or obliged to change the scope or nature of our
operations; significant costs, including adverse impacts on our
business, financial condition and results of operations, and
expenses associated with compliance with relevant regulations; and
if we fail to remediate the material weaknesses we identified in
our internal control over financial reporting or prevent material
weaknesses in the future, the accuracy and timing of our financial
statements may be impacted, which could result in material
misstatements in our financial statements or failure to meet our
reporting obligations and subject us to potential delisting,
regulatory investments or civil or criminal sanctions, and other
risks discussed under the caption “Risk Factors” in our
Registration Statement filed on Form F-1 with the SEC on October
21, 2024 and our other reports filed with the SEC.
The forward-looking statements made in this release relate only
to events or information as of the date on which the statements are
made in this release. Except as required by law, we undertake no
obligation to update or revise publicly any forward-looking
statements, whether as a result of new information, future events
or otherwise, after the date on which the statements are made or to
reflect the occurrence of unanticipated events.
Enquiries please contact:
Nicola Ratchford / Robert Coates
Marex
+44 (0) 7786548889 / +44 (0) 7880486329 | nratchford@marex.com / rcoates@marex.com
FTI Consulting US / UK
+1 (919) 609-9423 / +44 (0) 7776111 222 | marex@fticonsulting.com
Marex (NASDAQ:MRX)
Historical Stock Chart
From Oct 2024 to Nov 2024
Marex (NASDAQ:MRX)
Historical Stock Chart
From Nov 2023 to Nov 2024